Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.57 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.56 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.46 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | PPARD | Q03181 | 1/20 | 0.44 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.44 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.43 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2120551 | 1.00 | CA2 (0.57) | CA2CPB2CA1ZDHHC7MAPK1 | |
| SCHEMBL28793337 | 1.00 | CA2 (0.57) | CA2CPB2CA1ZDHHC7MAPK1 | |
| SCHEMBL18143477 | 1.00 | CA2 (0.57) | CA2CPB2CA1ZDHHC7MAPK1 | |
| SCHEMBL9000340 | 1.00 | CA2 (0.57) | CA2CPB2CA1ZDHHC7MAPK1 | |
| SCHEMBL3312232 | 1.00 | CA2 (0.57) | CA2CPB2CA1ZDHHC7MAPK1 | |
| SCHEMBL25341592 | 0.98 | CPB2 (0.58) | CA2CPB2CA1ZDHHC7GRIK1 | |
| SCHEMBL5516547 | 0.98 | CPB2 (0.58) | CA2CPB2CA1ZDHHC7GRIK1 | |
| SCHEMBL18531126 | 0.98 | CPB2 (0.58) | CA2CPB2CA1ZDHHC7GRIK1 | |
| SCHEMBL19148651 | 0.98 | CPB2 (0.58) | CA2CPB2CA1ZDHHC7GRIK1 | |
| SCHEMBL5580131 | 0.98 | CPB2 (0.58) | CA2CPB2CA1ZDHHC7GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 921 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118319784-A | Semitransparent cosmetic composition | 株式会社爱茉莉太平洋 | 2024-07-12 | — | — | CN | claimed |
| CN-115282087-B | Nanometer gold oil peptide capable of penetrating into dermis layer and preparation method and application thereof | 北京茂思商贸有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-115554199-B | Freckle-removing whitening repair face cream and preparation process thereof | 陕西恒远生物科技有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-118267341-A | Composition with long-acting anti-wrinkle, skin elasticity improving and tightening effects, and preparation method and application thereof | 仁和全域(上海)大健康研究院有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-117982352-B | Hair care gel with color protection function and preparation method and application thereof | 广州美兮生物科技有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-118256610-A | Method for screening active substance for improving skin inflammatory aging by using cell inflammatory aging model and active substance for improving skin inflammatory aging | 百特威(上海)化妆品有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-118178241-A | Cleansing composition, preparation method thereof and cleansing product | 水羊化妆品制造有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-118021693-B | Bright solid nourishing lipstick and preparation method thereof | 广州琦莉化妆品有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-118161426-A | Visualized particle coated with fat-soluble component and preparation method and application thereof | 广东芭薇生物科技股份有限公司 | 2024-06-11 | — | — | CN | claimed |
| CN-118141708-A | Oil-in-water type liquid cosmetic and preparation process thereof | 上海如妍化妆品有限公司 | 2024-06-07 | — | — | CN | claimed |
| US-10137200-B2 | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses | FOAMIX PHARMACEUTICALS LTD. (IL) | 2018-11-27 | — | — | US | claimed |
| US-20180193469-A1 | SURFACTANT-FREE WATER-FREE FOAMABLE COMPOSITIONS, BREAKABLE FOAMS AND GELS AND THEIR USES | FOAMIX PHARMACEUTICALS LTD. (IL) | 2018-07-12 | — | — | US | claimed |
| US-8992956-B2 | Cosmetic composition stabilized higher oily part | AMOREPACIFIC CORPORATION (KR) | 2015-03-31 | — | — | US | claimed |
| US-8945516-B2 | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses | FOAMIX PHARMACEUTICALS LTD. (IL) | 2015-02-03 | — | — | US | claimed |
| EP-2603193-A1 | SILICONE BASED COSMETIC COMPOSITIONS AND USES THEREOF | L'Oreal USA (US) | 2013-06-19 | — | — | EP | claimed |
| US-20120277313-A1 | COSMETIC COMPOSITION STABILIZED HIGHER OILY PART | AMOREPACIFIC CORPORATION (KR) | 2012-11-01 | — | — | US | claimed |
| WO-2012021577-A1 | SILICONE BASED COSMETIC COMPOSITIONS AND USES THEREOF | L'OREAL USA (US) | 2012-02-16 | — | — | WO | claimed |
| WO-2011065771-A2 | COSMETIC COMPOSITION STABILIZED HIGHER OILY PART | AMOREPACIFIC CORPORATION (KR) | 2011-06-03 | — | — | WO | claimed |
| CN-1684709-B | Medicine carrier for local application | VITAL HEALTH SCIENCES PTY LTD | 2010-05-26 | — | — | CN | claimed |
| CN-1684709-A | Medicine carrier for local application | VITAL HEALTH SCIENCES PTY LTD (AU) | 2005-10-19 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120277313-A1 | COSMETIC COMPOSITION STABILIZED HIGHER OILY PART | CUTA, ELOVL1, FDFT1 | CA2 3999/4885CPB2 4701/4885CA1 4745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.